CN100397083C - ELISA kit for detecting furazolidone metabolites and detection method thereof - Google Patents
ELISA kit for detecting furazolidone metabolites and detection method thereof Download PDFInfo
- Publication number
- CN100397083C CN100397083C CNB2005100867686A CN200510086768A CN100397083C CN 100397083 C CN100397083 C CN 100397083C CN B2005100867686 A CNB2005100867686 A CN B2005100867686A CN 200510086768 A CN200510086768 A CN 200510086768A CN 100397083 C CN100397083 C CN 100397083C
- Authority
- CN
- China
- Prior art keywords
- furaxone metabolite
- kit
- liquid
- antiantibody
- furaxone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- PLHJDBGFXBMTGZ-WEVVVXLNSA-N furazolidone Chemical class O1C([N+](=O)[O-])=CC=C1\C=N\N1C(=O)OCC1 PLHJDBGFXBMTGZ-WEVVVXLNSA-N 0.000 title claims abstract description 121
- 238000001514 detection method Methods 0.000 title abstract description 11
- 238000008157 ELISA kit Methods 0.000 title abstract 5
- 102000004190 Enzymes Human genes 0.000 claims abstract description 45
- 108090000790 Enzymes Proteins 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 42
- 239000000243 solution Substances 0.000 claims abstract description 21
- 241001465754 Metazoa Species 0.000 claims abstract description 19
- 239000012086 standard solution Substances 0.000 claims abstract description 18
- 239000007788 liquid Substances 0.000 claims description 59
- 241001597008 Nomeidae Species 0.000 claims description 36
- 239000000427 antigen Substances 0.000 claims description 26
- 102000036639 antigens Human genes 0.000 claims description 26
- 108091007433 antigens Proteins 0.000 claims description 26
- 238000002372 labelling Methods 0.000 claims description 23
- 239000008363 phosphate buffer Substances 0.000 claims description 22
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 19
- 238000002360 preparation method Methods 0.000 claims description 16
- 239000000872 buffer Substances 0.000 claims description 15
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 14
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 14
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 14
- 210000002966 serum Anatomy 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 14
- 238000012360 testing method Methods 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 12
- 238000010790 dilution Methods 0.000 claims description 11
- 239000012895 dilution Substances 0.000 claims description 11
- 230000001900 immune effect Effects 0.000 claims description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- 244000309466 calf Species 0.000 claims description 10
- 238000004140 cleaning Methods 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- 238000002203 pretreatment Methods 0.000 claims description 8
- 108010058846 Ovalbumin Proteins 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 7
- 229940092253 ovalbumin Drugs 0.000 claims description 7
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 6
- 241000894006 Bacteria Species 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 6
- 150000008064 anhydrides Chemical class 0.000 claims description 6
- 239000003550 marker Substances 0.000 claims description 6
- NFJCQBGAUBIGKV-UHFFFAOYSA-N nitro dihydrogen phosphate Chemical compound OP(O)(=O)O[N+]([O-])=O NFJCQBGAUBIGKV-UHFFFAOYSA-N 0.000 claims description 5
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 4
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 3
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 3
- 238000005406 washing Methods 0.000 abstract description 9
- 230000008569 process Effects 0.000 abstract description 5
- 230000008901 benefit Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 31
- 238000002835 absorbance Methods 0.000 description 20
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000012488 sample solution Substances 0.000 description 12
- 229960001625 furazolidone Drugs 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 10
- 239000012530 fluid Substances 0.000 description 10
- 230000003053 immunization Effects 0.000 description 10
- 238000002156 mixing Methods 0.000 description 10
- 238000002965 ELISA Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 238000004321 preservation Methods 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 241000251468 Actinopterygii Species 0.000 description 7
- 241000143060 Americamysis bahia Species 0.000 description 7
- 238000002347 injection Methods 0.000 description 7
- 239000007924 injection Substances 0.000 description 7
- 210000004080 milk Anatomy 0.000 description 7
- 239000008267 milk Substances 0.000 description 7
- 235000013336 milk Nutrition 0.000 description 7
- 239000002671 adjuvant Substances 0.000 description 6
- 230000002421 anti-septic effect Effects 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- 238000000576 coating method Methods 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 210000004408 hybridoma Anatomy 0.000 description 6
- 230000036039 immunity Effects 0.000 description 6
- 238000002649 immunization Methods 0.000 description 6
- 235000011121 sodium hydroxide Nutrition 0.000 description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 6
- 206010003445 Ascites Diseases 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 241000283705 Capra hircus Species 0.000 description 4
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 4
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 230000001804 emulsifying effect Effects 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 4
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000010355 oscillation Effects 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- CMWKITSNTDAEDT-UHFFFAOYSA-N 2-nitrobenzaldehyde Chemical compound [O-][N+](=O)C1=CC=CC=C1C=O CMWKITSNTDAEDT-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 2
- 230000000890 antigenic effect Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 238000001212 derivatisation Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 238000011587 new zealand white rabbit Methods 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000273 veterinary drug Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 206010007269 Carcinogenicity Diseases 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000007670 carcinogenicity Effects 0.000 description 1
- 231100000260 carcinogenicity Toxicity 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000002163 immunogen Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
Abstract
The present invention provides an ELISA kit for detecting furazolidone metabolites in animal foodstuff. The present invention comprises an enzyme mark plate which coats a furazolidone metabolite derivative antibody or an enzyme mark plate which coats an antiantibody, enzyme mark material, a furazolidone metabolite derivative peculiar antibody, furazolidone metabolite derivative standard solution, base material color developing solution, ending solution, concentration washing solution and concentration redissolution solution. The present invention also discloses a method which uses the ELISA kit to detect furazolidone metabolites. The method comprises the following steps: a sample is processed in advance; the sample is detected with the ELISA kit; finally, a detection result is analyzed. The ELISA kit and the method for detecting furazolidone metabolite residue in animal foodstuff, which are provided by the present invention, have the advantages that the pretreatment process of the sample is simple, the cost is low, and mass samples can be simultaneously detected.
Description
Technical field
The present invention relates to a kind of enzyme linked immunological kit and method that detects Furaxone metabolite in the animal derived food.
Background technology
Furazolidone (Furazolidone) is a kind of broad spectrum antibiotic of synthetic, and efficacy stability can suppress or kill multiple Gram-positive and negative bacteria, and some protozoon, fungi are had certain effect.Because efficient cheap, furazolidone has obtained using widely in herding, aquaculture.
But furazolidone residual in animal derived food can pass to the mankind by food chain, and long-term absorption can give rise to diseases.According to Food and Agricultural Organization of the United Nations (FAO) and The World Health Organization's food additives joint specialist committee report, furazolidone and metabolic product thereof have carcinogenicity, and easily produce drug resistance strain, cause monster easily.China classifies furazolidone as the forbidding medicine in March, 2002 in " veterinary drug and other compound inventory of food animal forbidding " by Ministry of Agriculture issue, and furazolidone enters and can metabolism becomes Furaxone metabolite and Furaxone metabolite has the harm same with furazolidone to human body very soon in the animal body.
Therefore the detection method of setting up a kind of effective Furaxone metabolite (AOZ) becomes task very critical in the residue of veterinary drug analysis field.At present, detect furazolidone residual method commonly used in aquatic products and the herding liquid chromatography (LC) and high performance liquid chromatography (HPLC) etc., these method sample pre-treatments complexity are arranged, the instrument cost height, operate loaded down with trivial detailsly, only be applicable to the conclusive evidence analysis of sample, and be not suitable for the examination of great amount of samples.
Summary of the invention
(1) technical matters that will solve
The purpose of this invention is to provide a kind of easy and simple to handle, expense is cheap, be applicable to the enzyme linked immunological kit and the method for Furaxone metabolite residual quantity in the detection animal derived food of great amount of samples examination.
(2) technical scheme
Detection principle of the present invention: be that Furaxone metabolite derivative hapten and thyroprotein conjugate (AOZ-BCG) are adsorbed on the solid phase carrier when coating antigen is Furaxone metabolite derivant coupled antigen, add sample or Furaxone metabolite derivant standard items, add the Furaxone metabolite specific antibody then, the Furaxone metabolite derivatives antigens competition Furaxone metabolite derivant specific antibody of bag quilt on residual Furaxone metabolite (after the pre-treatment derivatization) and the ELISA Plate in the testing sample.Add the enzyme labeling antiantibody again and carry out the amplification of enzymatic activity, the colour developing back stops, the absorbance of working sample, and the Furaxone metabolite residual quantity is negative correlation in this value and the sample, relatively can draw the concentration of Furaxone metabolite with typical curve.
Coating antigen is that antiantibody is adsorbed on the solid phase carrier during for antiantibody, add Furaxone metabolite derivant specific antibody, add Furaxone metabolite derivant enzyme-labelled antigen and sample or Furaxone metabolite derivant standard solution again, Furaxone metabolite (after the pre-treatment derivatization) and enzyme labeling Furaxone metabolite derivatives antigens residual in the sample to be tested are competed Furaxone metabolite derivant specific antibody, the colour developing back stops, the absorbance of working sample, the Furaxone metabolite residual quantity is negative correlation in this value and the sample, relatively can draw the concentration of Furaxone metabolite with typical curve, but with the standard solution color concentration range of Furaxone metabolite in the judgement sample more then.
The invention provides a kind of enzyme linked immunological kit that detects Furaxone metabolite in the animal derived food, it contains:
(1) bag by the elisa plate of Furaxone metabolite derivatives antigens or the bag by the elisa plate of antiantibody;
(2) enzyme labeling thing;
(3) Furaxone metabolite derivant specific antibody;
(4) Furaxone metabolite derivant standard solution;
(5) substrate colour developing liquid;
(6) stop buffer;
(7) concentrated cleaning solution;
(8) concentrate redissolution liquid.
Furaxone metabolite derivant envelope antigen adopts mixed anhydride method that Furaxone metabolite derivative hapten and thyroprotein are carried out coupling to obtain in the kit of the present invention, antiantibody can be sheep anti mouse antiantibody or goat-anti rabbit antiantibody, the sheep anti mouse antiantibody is to be that immunogene is carried out immunity to the pathogen-free domestic goat and obtained with mouse source antibody, and goat-anti rabbit antiantibody is to be that immunogene is carried out immunity to the pathogen-free domestic goat and obtained with rabbit source antibody.Used bag is cushioned the carbonate buffer solution of liquid for batch pH value 9.6,0.05mol/L in the preparation elisa plate process; Bag be can be polystyrene, cellulose, polyacrylamide, tygon, polypropylene, cross-link dextran, glass, silicon rubber, Ago-Gel etc. by the carrier mass of Furaxone metabolite derivatives antigens or antiantibody; The form of carrier can be test tube, micro-reaction plate shrinkage pool, globule, sequin etc.; Used cleansing solution is for containing 0.8%～1.2% polysorbas20 and 1 ‰ sodium azide (NaN
3) phosphate buffer of antiseptic; Used confining liquid is to contain 3%～10% the horse serum and the solution of 1% inert protein.
Bag by the elisa plate of Furaxone metabolite derivatives antigens or bag by the preparation process of the elisa plate of antiantibody is in the kit of the present invention:
(1) is cushioned liquid with bag the Furaxone metabolite derivative hapten is become antigenic dilution or antiantibody dilution with thyroprotein (BCG) conjugate or antiantibody with 0.02～0.08 μ g/ml concentration dilution;
(2) in every hole of elisa plate, add 100 μ l and diluted good antigenic dilution or antiantibody dilution, 37 ℃ of incubation 2h, and 4 ℃ spent the night, and the coating buffer that inclines, with cleansing solution washing 2 times, each 15～30s pats dry;
(3) in every hole of elisa plate, add 150～200 μ l confining liquids, 37 ℃ of incubation 1～2h, liquid in the hole of inclining, preserve with the vacuum seal of aluminium film dry back.
The elisa plate of above method preparation has good stability, and through cold and hot stability test, the correlation technique parameter of elisa plate is all in normal range, and coating antigen has good specificity.
The enzyme labeling thing is enzyme labeling antiantibody or enzyme labeling Furaxone metabolite derivatives antigens in the kit of the present invention, and used enzyme can be horseradish peroxidase or bacterium is extracted alkaline phosphatase, the preferred horseradish peroxidase of the present invention; Enzyme labeling thing form can be freeze-dried powder, concentrate and working fluid; The used dilution of enzyme labeling thing working fluid is for containing the solution of 50% glycerine (can prevent that the enzyme labeling thing of putting into-20 ℃ of environment from freezing, also can keep the biologically active of enzyme labeling thing for a long time), 1% sodium azide antiseptic (being convenient to preserve).
The preparation process of enzyme labeling antiantibody is in the kit of the present invention:
(1) preparation of antiantibody: with the mouse endogenous antibody is that immunogene is carried out immunity to the pathogen-free domestic goat, obtains the sheep anti mouse antiantibody; Or be that immunogene is carried out immunity to the pathogen-free domestic goat with the rabbit endogenous antibody, obtain goat-anti rabbit antiantibody.
(2) preparation of horseradish peroxidase-labeled antiantibody: antiantibody and horseradish peroxidase (HRP) are carried out coupling, the method that adopts is the sodium periodate method, adopt the sodium periodate method to make the combination rate of antiantibody and horseradish peroxidase raise, the molar concentration rate of enzyme and antiantibody is 4: 1 in traditional sodium periodate method requirement reaction system, be mixed with many condensates in the conjugate of preparation, because horseradish peroxidase produces many sites that combine with antiantibody under the effect of strong oxidation.Huo Hua horseradish peroxidase molecule has served as the bridge that connects each molecule like this, thereby reduces the enzymatic activity of enzyme labeling thing.In order to address this problem, the present invention improves traditional method, has saved amino closed process that is:, because can produce self amino amino reality that connects seldom; Reduce horseradish peroxidase simultaneously: the molar concentration rate to 2 of antiantibody: 1, the method after the improvement is easier than traditional method, and the loss of enzymatic activity is also reduced.
Enzyme-labelled antigen is to adopt active ester method that marker enzyme and Furaxone metabolite haptens are carried out coupling to obtain in the kit of the present invention.
Furaxone metabolite derivant specific antibody is mouse resource monoclonal antibody or rabbit source polyclonal antibody in the kit of the present invention, and immunogene adopts mixed anhydride method that Furaxone metabolite derivative hapten and ovalbumin are carried out coupling and obtains; Antibody formation can be freeze-dried powder, concentrate, working fluid; Antibody diluent is pH value 8.2,0.05mol/L, contain 3% calf serum and 5 ‰ N, the phosphate buffer of N '-dimethyl formamide (DMF).
Furaxone metabolite derivant specific antibody can be monoclonal antibody or polyclonal antibody in the kit of the present invention, and its preparation method is as follows:
(1) step of Furaxone metabolite derivant Monoclonal Antibody is:
A. animal immune program: adopt the Balb/c mouse as immune animal, immunogene (conjugate of Furaxone metabolite derivative hapten and ovalbumin) immunizing dose is 80～100 μ g/, Freund's complete adjuvant with immunogene and equivalent when head exempts from is mixed and made into emulsifying agent, the subcutaneous multi-point injection of nape portion, At intervals of two to three weeks is got the same dose immunogene and is added equivalent incomplete Freund mixing and emulsifying, booster immunization once, four exempt from the pneumoretroperitoneum booster immunization once, extracting spleen cell after 3 days;
B. Fusion of Cells and cloning: get immune Balb/c mouse boosting cell, in 5～10: 1 ratio and SP2/0 myeloma cell are merged, adopt indirect competitive ELISA to measure cell conditioned medium liquid, screen positive hole, utilize limiting dilution assay that cloning is carried out in positive hole, up to the hybridoma cell strain that obtains the stably excreting monoclonal antibody;
C. cell cryopreservation and recovery: get the hybridoma that is in exponential phase and make 1～5 * 10 with cryopreserving liquid
6The cell suspension of individual/ml is sub-packed in frozen pipe, in the medium-term and long-term preservation of liquid nitrogen, takes out frozen pipe during recovery, puts into 37 ℃ of water-bath middling speeds immediately and melts, and behind the centrifugal removal cryopreserving liquid, moves in the culture flask and cultivates;
D. MONOCLONAL ANTIBODIES SPECIFIC FOR and purifying: adopt in the body and induce method, Balb/c mouse (8 age in week) abdominal cavity is only injected sterilization paraffin oil 0.5ml/, 7～14 days pneumoretroperitoneum injection hybridomas 5 * 10
5～10
6Individual/as only, to gather ascites after 7～10 days, carry out the ascites purifying with sad-saturated ammonium sulfate method, bottle packing ,-20 ℃ of preservations;
E. the antibody freeze-dried powder can be dried ascites under 37 ℃ of environment, puts into-20 ℃ of preservations;
F. the antibody working fluid is with antibody diluent antibody to be diluted with 0.02～0.08 μ g/ml concentration.
(2) step of Furaxone metabolite derivant polyclonal antibody preparation is:
Adopt new zealand white rabbit as immune animal, immunogene (conjugate of Furaxone metabolite derivative hapten and ovalbumin) immunizing dose is 1mg/kg, Freund's complete adjuvant with immunogene and equivalent when head exempts from is mixed and made into emulsifying agent, the subcutaneous multi-point injection of nape portion, getting the same dose immunogene 3～4 weeks adds equivalent incomplete Freund mixing and emulsifying at interval, booster immunization once immune 5 times altogether, does not add adjuvant for the last time.Take a blood sample behind last immunity 7～10d, measure serum antibody titer, heart is taken a blood sample, and obtains the polyclonal antibody of purifying through ammonium sulfate precipitation.
In the kit of the present invention when marker enzyme is horseradish peroxidase substrate colour developing liquid A liquid be that hydrogen peroxide or urea peroxide, substrate colour developing liquid B liquid are that o-phenylenediamine or tetramethyl benzidine, stop buffer are sulfuric acid or the hydrochloride buffer of 1～2mol/L; When marker enzyme be bacterium when extracting alkaline phosphatase substrate colour developing liquid for being the NaOH of 2mol/L to nitro phosphate buffer, stop buffer; Concentrated cleaning solution is for containing 0.8%～1.2% polysorbas20 and 1 ‰ sodium azide (NaN
3) phosphate buffer of antiseptic; Concentrating redissolution liquid is the phosphate buffer that contains 50% methyl alcohol and 1% calf serum.
Furaxone metabolite derivant standard solution is the Furaxone metabolite derivative solution of six concentration gradients in the kit of the present invention, and Furaxone metabolite derivant dilution is for containing the phosphate buffer of 50% methyl alcohol, 1% calf serum (BSA).
The preparation of reagent is specially in the kit of the present invention:
A. Furaxone metabolite derivant standard solution: 6 bottles of Furaxone metabolite derivant series standard solution, concentration are 0 μ g/L, 0.05 μ g/L, 0.15 μ g/L, 0.45 μ g/L, 1.35 μ g/L, 4.05 μ g/L, 1～3ml/ bottle.
B. bag is cushioned liquid: the pH value is 9.6, the carbonate buffer solution of 0.05mol/L.
C. confining liquid: the solution that contains 3%～10% horse serum and 1% inert protein.
D. concentrated cleaning solution: contain 0.8%～1.2% polysorbas20,1 ‰ sodium azide (NaN
3) phosphate buffer (0.01M, pH7.4) of antiseptic, be 15～25 times of normal working concentration, 30-50ml/ bottle, 1 bottle.
E. enzyme labeling thing: enzyme labeling antiantibody working fluid or enzyme labeling Furaxone metabolite derivatives antigens working fluid, 7～12ml/ bottle, 1 bottle.
F. substrate colour developing liquid A liquid: hydrogen peroxide or urea peroxide;
G. substrate colour developing liquid B liquid: o-phenylenediamine (OPD) or tetramethyl benzidine (TMB);
H. substrate colour developing liquid to nitro phosphate buffer: pH8.1, contain MgCl
20.01%100mmolTris-HCl;
I. stop buffer: 1～2mol/L sulfuric acid, hydrochloric acid or 2mol/L sodium hydrate buffer solution, 5～8ml/ bottle, 1 bottle.
J. the 0.05mol/L of antibody diluent: pH8.2, contain 3% calf serum and 5 ‰ N, the phosphate buffer of N '-dimethyl formamide (DMF).
K. concentrate to redissolve liquid: contain the phosphate buffer of 50% methyl alcohol, 1% calf serum (BSA), be 5～10 times of normal working concentration, 30～50ml/ bottle, 1 bottle.
The method of Furaxone metabolite in the detection animal derived food of the present invention has comprised following steps:
(1) sample pre-treatments;
(2) detect with kit of the present invention;
(3) analyzing and testing result.
Sample-pretreating method is among the present invention:
(1) fishes and shrimps, muscle (pig, ox)
Get the equal pledge (fishes and shrimps/meat sample) of 1g, add the distilled water of 4ml successively, the 2-nitrobenzaldehyde of the HCL of 0.5ml 1M and 100ul 10mM, fully vibration.Sonic oscillation was hatched 3 hours in 37 ℃ after 1 hour, added 5ml 0.1M K respectively
2HPO
4, the ethyl acetate of 0.4ml 1M NaOH and 5ml, thermal agitation (20-25 ℃) under the room temperature after 30 seconds, 3000rpm are centrifugal, take out the ethyl acetate layer evaporate to dryness of 2.5ml.Normal hexane or normal heptane with 1ml dissolve dry thing, with the suitable mixing of redissolution liquid of 1ml.Room temperature (20-25 ℃), 3000rpm are centrifugal, get lower floor's liquid of 50ul and analyze.
The advantage of this method is: adopt sonic oscillation and hatch the reagent that can make adding to contact fully with sample, add the HCL quickening Furaxone metabolite of 1M and the decomposition of albumen to sample, significantly reduced the time of sample process.
(2) milk
Get 2ml milk,, remove upper strata fat, take off layer and analyze the centrifugal 10min of its 5000rpm.
The residual method of Furaxone metabolite in the detection animal derived food of the present invention has comprised following steps:
(1) sample pre-treatments;
(2) detection method:
A. in wrapping, add standard solution or sample solution and add Furaxone metabolite derivant specific antibody working fluid by the ELISA Plate micropore of Furaxone metabolite derivatives antigens, washing pats dry behind the incubation, add the enzyme labeling antiantibody then, incubation develops the color after washing plate, stop, measure absorbance with microplate reader;
B. in wrapping, add Furaxone metabolite derivant specific antibody working fluid by the ELISA Plate micropore of antiantibody, washing pats dry behind the incubation, add enzyme labeling Furaxone metabolite derivatives antigens then and add Furaxone metabolite derivant series standard product or sample solution, incubation develops the color after washing plate, stop, measure absorbance with microplate reader.
(3) analyzing and testing result.
(3) beneficial effect
Residual enzyme linked immunological kit and the method for Furaxone metabolite in the detection animal derived food provided by the invention, sample pretreatment process is simple, and expense is cheap, and can detect gross sample simultaneously.
Description of drawings
Fig. 1: the examination criteria curve map of Furaxone metabolite.
Embodiment
Further set forth the present invention below in conjunction with specific embodiment.Should be understood that these embodiment only are used to illustrate the present invention, and be not used for limiting the scope of the invention.
Embodiment 1 detects the preparation of the enzyme linked immunological kit component of Furaxone metabolite
1. antigen is synthetic
A. coating antigen is synthetic
Adopt derivative method to synthesize the Furaxone metabolite derivative hapten Furaxone metabolite, again haptens is carried out coupling by diazo-reaction and thyroprotein carrier protein with mixed anhydride method and obtain.
B. immunogenic synthetic
Adopt derivative method to synthesize the Furaxone metabolite derivative hapten Furaxone metabolite, again haptens is carried out coupling by diazo-reaction and ovalbumin carrier protein with mixed anhydride method and obtain.
2. the preparation of Furaxone metabolite derivant mouse monoclonal antibody
A. animal immune
Adopt the Balb/c mouse as immune animal, with Furaxone metabolite derivative hapten and ovalbumin conjugate is immunogene, immunizing dose is 100 μ g/, Freund's complete adjuvant with immunogene and equivalent when head exempts from is mixed and made into emulsifying agent, the subcutaneous multi-point injection of nape portion, getting the same dose immunogene 2 weeks adds equivalent incomplete Freund mixing and emulsifying at interval, and booster immunization is once, four exempt from the pneumoretroperitoneum booster immunization once, extracting spleen cell after 3 days.
B. Fusion of Cells and cloning
Get immune Balb/c mouse boosting cell, merge, adopt indirect competitive ELISA to measure cell conditioned medium liquid, screen positive hole in 5: 1 ratios and SP2/0 myeloma cell.Utilize limiting dilution assay that cloning is carried out in positive hole, up to the hybridoma cell strain that obtains the stably excreting monoclonal antibody.
C. cell cryopreservation and recovery
Get the hybridoma that is in exponential phase and make 5 * 10 with cryopreserving liquid
6The cell suspension of individual/ml is sub-packed in frozen pipe, in the medium-term and long-term preservation of liquid nitrogen.Take out frozen pipe during recovery, put into 37 ℃ of water-bath middling speeds immediately and melt, behind the centrifugal removal cryopreserving liquid, move in the culture flask and cultivate.
D. MONOCLONAL ANTIBODIES SPECIFIC FOR and purifying
Adopt in the body and induce method, the Balb/c mouse peritoneal injection in 8 ages in week is only sterilized paraffin oil 0.5ml/, 7 days pneumoretroperitoneum injection hybridomas 5 * 10
6Individual/as only, to gather ascites after 7 days.Carry out the ascites purifying with sad-saturated ammonium sulfate method, bottle packing ,-20 ℃ of preservations.
3. the preparation of Furaxone metabolite derivant rabbit polyclonal antibody
Adopt new zealand white rabbit as immune animal, with Furaxone metabolite derivative hapten and ovalbumin conjugate is immunogene, immunizing dose is 1mg/kg, Freund's complete adjuvant with immunogene and equivalent when head exempts from is mixed and made into emulsifying agent, the subcutaneous multi-point injection of nape portion, getting the same dose immunogene 3 weeks adds equivalent incomplete Freund mixing and emulsifying at interval, and booster immunization is once, immunity is 5 times altogether, does not add adjuvant for the last time.Take a blood sample behind the last immune 7d, measure serum antibody titer, heart is taken a blood sample, and obtains the polyclonal antibody of purifying through ammonium sulfate precipitation.
4. the preparation of ELISA Plate
Be cushioned liquid with bag goat-anti rabbit antiantibody is diluted to 0.06 μ g/ml, every hole adds 100 μ l, 37 ℃ of incubation 2h, and 4 ℃ of environment spend the night, coating buffer inclines, with cleansing solution washing 2 times, each 1min pats dry, in every hole, add 150 μ l confining liquids then, 37 ℃ of incubation 1h, liquid in the hole of inclining, preserve with the vacuum seal of aluminium film dry back.
Embodiment 2 detects the establishment of the enzyme linked immunological kit of Furaxone metabolite
Set up the enzyme linked immunological kit that detects Furaxone metabolite, make it comprise following component:
(1) bag is by the elisa plate of Furaxone metabolite derivatives antigens;
(2) the sheep anti mouse antiantibody of usefulness horseradish peroxidase-labeled;
(3) Furaxone metabolite derivant mouse monoclonal antibody;
(4) the Furaxone metabolite standard solution is 6 bottles, and concentration is respectively 0 μ g/L, 0.05 μ g/L, 0.15 μ g/L, 0.45 μ g/L, 1.35 μ g/L, 4.05 μ g/L;
(5) substrate colour developing liquid A liquid is hydrogen peroxide, and substrate colour developing liquid B liquid is o-phenylenediamine;
(6) stop buffer is the phosphate buffer of 2mol/L;
(7) concentrated cleaning solution is pH7.4, contains 0.8% polysorbas20 and 1 ‰ sodium azide (NaN
3) phosphate buffer of antiseptic;
(8) antibody diluent is pH value 8.2,0.05mol/L, contains 3% calf serum and 5 ‰ N, the phosphate buffer of N '-dimethyl formamide (DMF);
(9) concentrate redissolution liquid for containing the phosphate buffer of 50% methyl alcohol, 1% calf serum (BSA).
Embodiment 3 detect Furaxone metabolites enzyme linked immunological kit establishment
Set up the enzyme linked immunological kit that detects Furaxone metabolite, make it comprise following component:
(1) bag is by the elisa plate of goat-anti rabbit antiantibody;
(2) the Furaxone metabolite derivatives antigens of usefulness alkaline phosphate ester enzyme labeling;
(3) Furaxone metabolite derivant rabbit polyclonal antibody;
(4) Furaxone metabolite derivant standard solution is 6 bottles, and concentration is respectively 0 μ g/L, 0.05 μ g/L, 0.15 μ g/L, 0.45 μ g/L, 1.35 μ g/L, 4.05 μ g/L;
(5) substrate colour developing liquid is to the nitro phosphate buffer;
(6) stop buffer is the sodium hydrate buffer solution of 2mol/L;
(7) concentrated cleaning solution is PH7.4, contains 0.8% polysorbas20 and 1 ‰ sodium azide (NaN
3) phosphate buffer of antiseptic;
(8) concentrate redissolution liquid for containing the phosphate buffer of 50% methyl alcohol, 1% calf serum (BSA).
The residual detection of Furaxone metabolite in embodiment 4 samples
1. sample pre-treatments
Get the equal pledge of 1g fishes and shrimps, add the distilled water of 4ml successively, the 2-nitrobenzaldehyde of the HCL of 0.5ml 1M and 100 μ l10mM, fully vibration.Sonic oscillation was hatched 3 hours in 37 ℃ after 1 hour, added 5ml 0.1M K respectively
2HPO
4, the ethyl acetate of 0.4ml 1M NaOH and 5ml, 30 seconds of thermal agitation, at room temperature (20-25 ℃) was centrifugal, and rotating speed is 3000rpm.Take out the ethyl acetate layer evaporate to dryness of 2.5ml, with the dry thing of the n-hexane dissolution of 1ml, with the suitable mixing of redissolution liquid of 1ml.Centrifugal in room temperature (20-25 ℃), 3000rpm.Lower floor's liquid with 50ul is analyzed.
2. detect with kit
In 96 hole ELISA Plate micropores of Furaxone metabolite derivant coupled antigen bag quilt, add series standard product or sample solution (each 2 hole) 50 μ l, add Furaxone metabolite derivant antibody working fluid 50 μ l again, with cover plate film shrouding, react 60min in 20～25 ℃ of constant temperature ovens.Pour out liquid in the hole, every hole adds 250 μ l concentrated cleaning solutions, pours out liquid in the hole after 30 seconds, and so repetitive operation is washed plate 5 times altogether, pats dry with thieving paper.Every hole adds the sheep anti mouse antiantibody 100 μ l of horseradish peroxidase-labeled, with cover plate film shrouding, reacts 30min in 20～25 ℃ of constant temperature ovens, repeated washing work.Add substrate colour developing liquid A liquid hydrogen peroxide 50 μ l, add B liquid o-phenylenediamine 50 μ l again, the mixing that vibrates gently, 20～25 ℃ of constant temperature oven lucifuge colour developing 30min.Every hole adds stop buffer 2mol/L sulfuric acid 50 μ l, and the mixing that vibrates is gently measured every hole absorbance with microplate reader.
3. testing result analysis
With the absorbance mean value (B) of the standard solution of each concentration that is obtained absorbance (B divided by first standard solution (0 standard)
0) multiply by 100% again, obtain the percentage absorbance.Semilog with Furaxone metabolite concentration is an X-axis, and the percentage absorbance is a Y-axis, the drawing standard curve map.Percentage absorbance with same way calculation sample solution, in the percentage absorbance substitution typical curve with sample solution, read the pairing concentration of Furaxone metabolite the sample solution from typical curve, multiply by the actual concentrations that its corresponding extension rate is Furaxone metabolite in the sample solution.
The residual detection of Furaxone metabolite in embodiment 5 samples
1. sample pre-treatments
Get 2ml milk, it is put the centrifugal 10min of 5000rpm, remove upper strata fat, take off layer 50 μ l, the redissolution liquid that kit provided is by 1: 40 times of dilution.
2. detect with kit
In 96 hole ELISA Plate micropores of goat-anti rabbit antiantibody bag quilt, add Furaxone metabolite derivant rabbit polyclonal antibody working fluid 100 μ l, with cover plate film shrouding, react 60min in 20～25 ℃ of constant temperature ovens, pour out liquid in the hole, every hole adds 250 μ l concentrated cleaning solutions, pour out liquid in the hole after 30 seconds, so repetitive operation is washed plate 5 times altogether, pats dry with thieving paper.Every hole adds the Furaxone metabolite derivatives antigens 50 μ l that bacterium is extracted the alkaline phosphate ester enzyme labeling, adds series standard product or sample solution 50 μ l again, with cover plate film shrouding, reacts 30min in 20～25 ℃ of constant temperature ovens, the repeated washing process.Adding is to nitro phosphate buffer 1 00 μ l, the mixing that vibrates gently, 20～25 ℃ of constant temperature oven lucifuges colour developing 30min.Every hole adds stop buffer 2mol/L NaOH 50 μ l, and the mixing that vibrates is gently measured every hole absorbance with microplate reader.
3. testing result analysis
With the absorbance mean value (B) of the standard solution of each concentration that is obtained absorbance (B divided by first standard solution (0 standard)
0) multiply by 100% again, obtain the percentage absorbance.Semilog with Furaxone metabolite derivatives concentration (μ g/L) is an X-axis, and the percentage absorbance is a Y-axis, the drawing standard curve map.Percentage absorbance with same way calculation sample solution, in the percentage absorbance substitution typical curve with sample solution, read the pairing concentration of sample solution from typical curve, multiply by its corresponding extension rate and be Furaxone metabolite actual concentrations in the sample solution.
The test of experimental example 1 standard items precision
From every batch of elisa plate according to the preparation of the method the embodiment 1 (4), each extracts 10 micropores out, measures the absorbance (OD value) of 0.45 μ g/L standard solution, repeats 3 times, calculates coefficient of variation CV%, the results are shown in Table 1.
The repeatable test of table 1 standard (CV%)
The result shows coefficient of variation scope between 3.5%～9.4%, has met the coefficient of variation less than 20% regulation, illustrates that this kit standard items precision has reached standard.
The repeatable test of experimental example 2 samples
, add in the sample fishes and shrimps, muscle and milk with the Furaxone metabolite of 0.5 μ g/L concentration, get each five of the kits of three different batches respectively, each concentration repeats 5 times, calculates the coefficient of variation respectively, the results are shown in Table 2～3.
Table 2 fishes and shrimps, the repeatable test of muscle samples
The repeatable test of table 3 milk sample
The result shows that fishes and shrimps, muscle sample coefficient of variation all are lower than 20%, the Variation Lines number average of milk sample is lower than 20%, has met the coefficient of variation less than 25% regulation, illustrates that the precision of this kit measurement sample has reached standard.
The accuracy test of experimental example 3 kits
Get the furazolidone metabolite standard solution of two concentration, be respectively 0.5 μ g/kg (L) and 1 μ g/kg (L), respectively sample is added recovery test, each concentration do 4 parallel, calculate recovery rate respectively.
The accuracy of table 4 kit
The result shows the recovery of fishes and shrimps, muscle interpolation between 73.4%～92.8%, and milk adds the recovery between 73.5%～86.1%.
Experimental example 4
The kit preservation condition is 2-8 ℃, and through 6 months mensuration, the maximum absorbance value (zero standard) of kit, 50% inhibition concentration, Furaxone metabolite added the practical measurement value all within normal range.Consideration has improper preservation condition and occurs in transportation and use, and kit was placed 6 days under the condition of 37 ℃ of preservations, carries out the accelerated deterioration experiment, and the result shows that the every index of this kit meets the requirements fully.Consider that the freezing situation of kit takes place, kit was put into-20 ℃ of refrigerators freezing 5 days, measurement result shows that also the every index of kit is normal fully.Can draw kit from above result can preserve more than 6 months at 2-8 ℃.
Claims (7)
1. enzyme linked immunological kit that detects Furaxone metabolite in the animal derived food,
It is characterized in that it contains:
(1) bag by the elisa plate of Furaxone metabolite derivatives antigens or the bag by the elisa plate of antiantibody;
(2) enzyme labeling thing;
(3) Furaxone metabolite derivant specific antibody;
(4) Furaxone metabolite derivant standard solution;
(5) substrate colour developing liquid;
(6) stop buffer;
(7) concentrated cleaning solution;
(8) concentrate redissolution liquid;
Wherein Furaxone metabolite derivant envelope antigen adopts mixed anhydride method that Furaxone metabolite derivative hapten and thyroprotein are carried out coupling to obtain, and described Furaxone metabolite derivant antibody is by described antigen preparation acquisition.
2. kit as claimed in claim 1 is characterized in that: bag is sheep anti mouse antiantibody or goat-anti rabbit antiantibody by antiantibody.
3. kit as claimed in claim 1 is characterized in that: the enzyme labeling thing is enzyme labeling antiantibody or enzyme labeling Furaxone metabolite derivatives antigens, and used marker enzyme is that horseradish peroxidase or bacterium are extracted alkaline phosphatase.
4. as the arbitrary described kit of claim 1-3, it is characterized in that: when marker enzyme was horseradish peroxidase, substrate colour developing liquid A liquid was that hydrogen peroxide or urea peroxide, substrate colour developing liquid B liquid are that o-phenylenediamine or tetramethyl benzidine, stop buffer are sulfuric acid or the hydrochloride buffer of 1～2mol/L; When marker enzyme is a bacterium when extracting alkaline phosphatase, substrate colour developing liquid is for being the NaOH of 2mol/L to nitro phosphate buffer, stop buffer; Concentrated cleaning solution is the phosphate buffer that contains 0.8%～1.2% polysorbas20 and 1 ‰ sodium azide; Concentrating redissolution liquid is the phosphate buffer that contains 50% methyl alcohol and 1% calf serum.
5. kit as claimed in claim 4, it is characterized in that: Furaxone metabolite derivant standard solution is the Furaxone metabolite derivative solution of six concentration gradients, and Furaxone metabolite derivant dilution is the phosphate buffer that contains 50% methyl alcohol and 1% calf serum.
6. as claim 1 or 5 described kits, it is characterized in that: Furaxone metabolite derivant specific antibody is mouse resource monoclonal antibody or rabbit source polyclonal antibody, and immunogene adopts mixed anhydride method that Furaxone metabolite derivative hapten and ovalbumin are carried out coupling and obtains.
7. method that detects Furaxone metabolite in the animal derived food comprises step:
(1) sample pre-treatments;
(2) the arbitrary described kit with claim 1-6 detects;
(3) analyzing and testing result.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100867686A CN100397083C (en) | 2005-11-03 | 2005-11-03 | ELISA kit for detecting furazolidone metabolites and detection method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100867686A CN100397083C (en) | 2005-11-03 | 2005-11-03 | ELISA kit for detecting furazolidone metabolites and detection method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1766624A CN1766624A (en) | 2006-05-03 |
| CN100397083C true CN100397083C (en) | 2008-06-25 |
Family
ID=36742628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100867686A Expired - Fee Related CN100397083C (en) | 2005-11-03 | 2005-11-03 | ELISA kit for detecting furazolidone metabolites and detection method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100397083C (en) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101013129B (en) * | 2007-02-13 | 2011-08-17 | 北京望尔生物技术有限公司 | Enzyme linked immunosorbent reagent casing for detecting furacilin metabolite and uses thereof |
| CN101013131B (en) * | 2007-02-13 | 2011-08-17 | 北京望尔康泰生物技术有限公司 | Furantoin metabolite enzyme linked immunosorbent analytical reagent casing and uses thereof |
| CN101021536B (en) * | 2007-03-12 | 2011-06-22 | 北京望尔康泰生物技术有限公司 | ELISA kit and method for detecting neomycin drug |
| CN101021535B (en) * | 2007-03-12 | 2011-06-22 | 北京望尔康泰生物技术有限公司 | Enzyme-linked immunosorbent assay kit and method for detecting gentamicin drug |
| CN101256188B (en) * | 2008-04-16 | 2012-07-11 | 北京望尔生物技术有限公司 | ELISA kit for detecting lincomycin medicine as well as usage thereof |
| CN102621326B (en) * | 2012-02-23 | 2014-08-06 | 苏州大学 | Method for detecting furaltadone metabolite content in food |
| CN103364546B (en) * | 2012-04-05 | 2016-03-30 | 北京勤邦生物技术有限公司 | A kind of kit and method detecting Furaxone metabolite |
| CN103575914B (en) * | 2012-08-02 | 2016-08-03 | 北京勤邦生物技术有限公司 | The enzyme linked immunological kit of detection vitamin B12 and application thereof |
| CN104569407B (en) * | 2014-12-25 | 2017-06-06 | 深圳市康博霖科技有限公司 | A kind of construction method of mycotoxin Test database, mycotoxin detection method, kit and device |
| CN106501521A (en) * | 2016-10-21 | 2017-03-15 | 河北省科学院生物研究所 | A kind of enzyme linked immunological kit of detection Furaxone metabolite and preparation method and application |
| CN106706617A (en) * | 2016-12-07 | 2017-05-24 | 百奥森（江苏）食品安全科技有限公司 | Detection method and kit for detecting furazolidone metabolite in animal tissues |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1030300A (en) * | 1987-06-15 | 1989-01-11 | 科特公司 | Utilize the enzyme-labeled immunity detection method to measure antigen and/or antibody in the human body simultaneously |
| US6287807B1 (en) * | 1997-09-25 | 2001-09-11 | Smithkline Beecham Corporation | MurF |
| CN1547013A (en) * | 2003-12-08 | 2004-11-17 | 中国农业大学 | A kind of ELISA kit for detecting sulfamethazine |
| CN1731185A (en) * | 2005-09-02 | 2006-02-08 | 华中农业大学 | An enzyme-linked immunoassay kit suitable for furazolidone residue analysis and its application |
-
2005
- 2005-11-03 CN CNB2005100867686A patent/CN100397083C/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1030300A (en) * | 1987-06-15 | 1989-01-11 | 科特公司 | Utilize the enzyme-labeled immunity detection method to measure antigen and/or antibody in the human body simultaneously |
| US6287807B1 (en) * | 1997-09-25 | 2001-09-11 | Smithkline Beecham Corporation | MurF |
| CN1547013A (en) * | 2003-12-08 | 2004-11-17 | 中国农业大学 | A kind of ELISA kit for detecting sulfamethazine |
| CN1731185A (en) * | 2005-09-02 | 2006-02-08 | 华中农业大学 | An enzyme-linked immunoassay kit suitable for furazolidone residue analysis and its application |
Non-Patent Citations (2)
| Title |
|---|
| 动物源性食品中呋喃唑酮及其代谢物的检测. 郭桢等.广东农业科学，第5期. 2005 |
| 动物源性食品中呋喃唑酮及其代谢物的检测. 郭桢等.广东农业科学，第5期. 2005 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1766624A (en) | 2006-05-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101256188B (en) | ELISA kit for detecting lincomycin medicine as well as usage thereof | |
| CN102955031B (en) | Enzyme-linked immunosorbent assay kit for detecting aflatoxin B1-containing medicine and application for same | |
| CN101013130A (en) | Enzyme linked immunosorbent reagent casing for detecting furantoin metabolite and uses thereof | |
| CN101571539B (en) | Elisa kit for detecting cephalo-type medicine and application thereof | |
| CN103018454B (en) | A kind of chemical luminescence ELISA detection kit of sulfa drugs | |
| CN102967709B (en) | Detect enzyme linked immunological kit and the application thereof of zearalenone medicine | |
| CN101021536B (en) | ELISA kit and method for detecting neomycin drug | |
| CN100397083C (en) | ELISA kit for detecting furazolidone metabolites and detection method thereof | |
| CN101776685B (en) | Enzyme linked immunosorbent assay kit for detecting trimethoprim medicament and application thereof | |
| CN101839918B (en) | Method for detecting spiramycin and special enzyme-linked immunoassay kit thereof | |
| CN101021535B (en) | Enzyme-linked immunosorbent assay kit and method for detecting gentamicin drug | |
| CN101526537A (en) | Elisa reagent for detecting chloramphenicol and method thereof | |
| CN101299046B (en) | Method for detecting erythromycin compounds and special enzyme-linked immunoassay kit thereof | |
| CN101349693A (en) | Fluorobenzene niekau series medicament fast detecting reagent kit and uses thereof | |
| CN101013131A (en) | Furantoin metabolite enzyme linked immunosorbent analytical reagent casing and uses thereof | |
| CN101526528A (en) | Furaltadone metabolite detection kit | |
| CN100489530C (en) | Method for assaying sulfaquinoxaline and special enzyme-linked immune reagent kit | |
| CN101571540A (en) | Enzyme-linked immunosorbent kit for inspecting porcine immunoglobulin G and application thereof | |
| CN101358967B (en) | Method for detecting chlorpromazine and special ELISA kit thereof | |
| CN101349699A (en) | Furaltadone metabolite detection reagent kit | |
| CN100492009C (en) | ELISA kit for detecting fluoromethylquinoline and detection method thereof | |
| CN103808931A (en) | Enzyme linked immunosorbent assay kit for detecting sulfadiazine and detection method thereof | |
| CN105273021A (en) | Erythromycin hapten, erythromycin artificial antigen, erythromycin antibody, preparation methods of erythromycin hapten and erythromycin artificial antigen, and uses of erythromycin hapten and erythromycin antibody | |
| CN103792226A (en) | Chemiluminescence immunodetection kit used for detecting phenylethanolamine A | |
| CN100501405C (en) | ELISA kit for detecting penicillin G and detection method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Effective date of registration: 20090803 Pledge (preservation): Pledge |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20100712 Granted publication date: 20080625 Pledgee: Bank of Communications Ltd. Beijing Zhongguancun Park sub branch Pledgor: Beijing Wanger Biotechnology Co.,Ltd.|Beijing Wanger Kangtai Biotechnology Co.,Ltd. Registration number: 2009110000584 |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080625 |